Labcorp Holdings (LH) Revenue & Revenue Breakdown
Labcorp Holdings Revenue Highlights
Latest Revenue (Y)
$12.16B
Latest Revenue (Q)
$3.53B
Main Segment (Y)
LabCorp Diagnostics
Main Geography (Y)
North America
Labcorp Holdings Revenue by Period
Labcorp Holdings Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $12.16B | -18.25% |
| 2022-12-31 | $14.88B | -7.72% |
| 2021-12-31 | $16.12B | 15.33% |
| 2020-12-31 | $13.98B | 20.98% |
| 2019-12-31 | $11.55B | 1.95% |
| 2018-12-31 | $11.33B | 8.54% |
| 2017-12-31 | $10.44B | 8.29% |
| 2016-12-31 | $9.64B | 11.08% |
| 2015-12-31 | $8.68B | 44.39% |
| 2014-12-31 | $6.01B | 3.50% |
| 2013-12-31 | $5.81B | 2.41% |
| 2012-12-31 | $5.67B | 2.33% |
| 2011-12-31 | $5.54B | 10.76% |
| 2010-12-31 | $5.00B | 6.59% |
| 2009-12-31 | $4.69B | 4.21% |
| 2008-12-31 | $4.51B | 10.74% |
| 2007-12-31 | $4.07B | 13.30% |
| 2006-12-31 | $3.59B | 7.91% |
| 2005-12-31 | $3.33B | 7.87% |
| 2004-12-31 | $3.08B | 4.95% |
| 2003-12-31 | $2.94B | 17.21% |
| 2002-12-31 | $2.51B | 14.00% |
| 2001-12-31 | $2.20B | 14.61% |
| 2000-12-31 | $1.92B | 12.99% |
| 1999-12-31 | $1.70B | 5.34% |
| 1998-12-31 | $1.61B | 6.16% |
| 1997-12-31 | $1.52B | -5.52% |
| 1996-12-31 | $1.61B | 12.27% |
| 1995-12-31 | $1.43B | 64.13% |
| 1994-12-31 | $872.50M | 14.73% |
| 1993-12-31 | $760.50M | - |
Labcorp Holdings generated $12.16B in revenue during NA 2023, up -18.25% compared to the previous quarter, and up 107.31% compared to the same period a year ago.
Labcorp Holdings Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $3.53B | 5.45% |
| 2025-03-31 | $3.35B | 0.47% |
| 2024-12-31 | $3.33B | 1.44% |
| 2024-09-30 | $3.28B | 1.90% |
| 2024-06-30 | $3.22B | 1.39% |
| 2024-03-31 | $3.18B | 4.72% |
| 2023-12-31 | $3.03B | -0.77% |
| 2023-09-30 | $3.06B | 0.76% |
| 2023-06-30 | $3.03B | -19.70% |
| 2023-03-31 | $3.78B | 2.82% |
| 2022-12-31 | $3.67B | 1.89% |
| 2022-09-30 | $3.61B | -2.46% |
| 2022-06-30 | $3.70B | -5.20% |
| 2022-03-31 | $3.90B | -3.86% |
| 2021-12-31 | $4.06B | -0.16% |
| 2021-09-30 | $4.06B | 5.78% |
| 2021-06-30 | $3.84B | -7.71% |
| 2021-03-31 | $4.16B | -7.31% |
| 2020-12-31 | $4.49B | 15.24% |
| 2020-09-30 | $3.90B | 40.71% |
| 2020-06-30 | $2.77B | -1.95% |
| 2020-03-31 | $2.82B | -4.39% |
| 2019-12-31 | $2.95B | 0.85% |
| 2019-09-30 | $2.93B | 1.62% |
| 2019-06-30 | $2.88B | 3.24% |
| 2019-03-31 | $2.79B | 0.13% |
| 2018-12-31 | $2.79B | -1.55% |
| 2018-09-30 | $2.83B | -1.22% |
| 2018-06-30 | $2.87B | 0.63% |
| 2018-03-31 | $2.85B | 1.86% |
| 2017-12-31 | $2.80B | 5.31% |
| 2017-09-30 | $2.66B | 4.42% |
| 2017-06-30 | $2.54B | 3.92% |
| 2017-03-31 | $2.45B | 0.77% |
| 2016-12-31 | $2.43B | 0.57% |
| 2016-09-30 | $2.41B | -0.66% |
| 2016-06-30 | $2.43B | 2.65% |
| 2016-03-31 | $2.37B | 2.19% |
| 2015-09-30 | $2.32B | 2.12% |
| 2015-06-30 | $2.27B | 26.54% |
| 2015-03-31 | $1.79B | 18.54% |
| 2014-12-31 | $1.51B | -2.52% |
| 2014-09-30 | $1.55B | 2.33% |
| 2014-06-30 | $1.52B | 5.99% |
| 2014-03-31 | $1.43B | -0.44% |
| 2013-12-31 | $1.44B | -1.72% |
| 2013-09-30 | $1.46B | -0.41% |
| 2013-06-30 | $1.47B | 1.89% |
| 2013-03-31 | $1.44B | 2.53% |
| 2012-12-31 | $1.41B | -0.99% |
| 2012-09-30 | $1.42B | -0.28% |
| 2012-06-30 | $1.42B | 0.01% |
| 2012-03-31 | $1.42B | 4.19% |
| 2011-12-31 | $1.37B | -2.73% |
| 2011-09-30 | $1.40B | 0.09% |
| 2011-06-30 | $1.40B | 2.55% |
| 2011-03-31 | $1.37B | 5.64% |
| 2010-12-31 | $1.30B | 1.48% |
| 2010-09-30 | $1.28B | 3.08% |
| 2010-06-30 | $1.24B | 3.75% |
| 2010-03-31 | $1.19B | 2.45% |
| 2009-12-31 | $1.17B | -1.69% |
| 2009-09-30 | $1.19B | -0.31% |
| 2009-06-30 | $1.19B | 2.86% |
| 2009-03-31 | $1.16B | 3.27% |
| 2008-12-31 | $1.12B | -1.41% |
| 2008-09-30 | $1.14B | -1.11% |
| 2008-06-30 | $1.15B | 4.04% |
| 2008-03-31 | $1.10B | 9.68% |
| 2007-12-31 | $1.01B | - |
Labcorp Holdings generated $3.53B in revenue during Q2 2025, up 5.45% compared to the previous quarter, and up 111.04% compared to the same period a year ago.
Labcorp Holdings Revenue Breakdown
Labcorp Holdings Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 24 | Dec 22 | Dec 21 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| LabCorp Diagnostics | $10.14B | $7.00B | $7.03B | - | - |
| Drug Development | - | $5.71B | $11.69B | - | - |
| Diagnostics | - | $9.20B | $20.73B | - | - |
| Covance Drug Development | - | - | - | $4.58B | $4.31B |
Labcorp Holdings's latest annual revenue breakdown by segment (product or service), as of Dec 24: LabCorp Diagnostics (100.00%).
Quarterly Revenue by Product
| Product/Service | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 |
|---|---|---|---|---|---|---|---|---|---|
| LabCorp Diagnostics | $2.75B | $2.63B | $2.59B | $2.55B | $2.52B | $2.48B | - | - | - |
| Covance Drug Development | - | - | - | $737.70M | $707.00M | $710.90M | - | - | - |
| Diagnostics | - | - | - | - | - | $2.48B | $9.42B | $2.34B | $2.34B |
| Drug Development | - | - | - | - | - | $710.90M | $2.77B | $719.10M | $699.00M |
Labcorp Holdings's latest quarterly revenue breakdown by segment (product or service), as of Jun 25: LabCorp Diagnostics (100.00%).
Labcorp Holdings Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|
| North America | $13.09B | $11.53B | - | - |
| Europe | $2.05B | $1.51B | - | - |
| Other countries | $976.40M | $941.00M | $1.20B | $1.18B |
Labcorp Holdings's latest annual revenue breakdown by geography, as of Dec 21: North America (81.22%), Europe (12.72%), and Other countries (6.06%).
Quarterly Revenue by Country
| Country | Jun 25 | Mar 25 | Sep 24 | Jun 24 | Mar 24 | Sep 23 | Jun 23 | Dec 21 |
|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $2.93B | $2.81B | $2.74B | $2.70B | $2.65B | $2.55B | $2.54B | - |
| Europe | - | - | - | - | - | - | - | $2.05B |
| Other countries | - | - | - | - | - | - | - | $976.40M |
| North America | - | - | - | - | - | - | - | $13.09B |
Labcorp Holdings's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (100.00%).